Search

Your search keyword '"Hasle, Henrik"' showing total 119 results

Search Constraints

Start Over You searched for: Author "Hasle, Henrik" Remove constraint Author: "Hasle, Henrik" Database ScienceDirect Remove constraint Database: ScienceDirect
119 results on '"Hasle, Henrik"'

Search Results

1. ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies

2. Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

3. A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

4. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

7. Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome

9. European standard clinical practice – Key issues for the medical care of individuals with familial leukemia

10. Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration

11. Psychiatric disorders in childhood cancer survivors in Denmark, Finland, and Sweden: a register-based cohort study from the SALiCCS research programme

14. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group

15. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL

20. P6 - NPM1 MUTATIONS IN CHILDREN WITH MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS

21. OC 20 - GENOTYPE/PHENOTYPE ASSOCIATIONS IN 174 INDIVIDUALS WITH GERMLINE GATA2 MUTATIONS

24. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents

25. LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia

27. Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study

29. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group

31. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

33. Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML

34. Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study

35. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome

37. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2

39. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study

45. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial

47. Treatment Outcomes of Childhood Picalm:MLLT10+ Acute Leukemias: An International Retrospective Study

48. UBTF tandem Duplications Account for a Third of Advanced Pediatric MDS without Genetic Predisposition to Myeloid Neoplasia

49. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7

50. Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment

Catalog

Books, media, physical & digital resources